<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03653416</url>
  </required_header>
  <id_info>
    <org_study_id>GCO 17-04304</org_study_id>
    <secondary_id>IRB 17-01981</secondary_id>
    <nct_id>NCT03653416</nct_id>
  </id_info>
  <brief_title>Efficacy of Ipack Block and Surgeon's Joint Infiltration in Total Knee Arthroplasty</brief_title>
  <official_title>Comparison Between Ipack Block and Periarticular Infiltration in Total Knee Arthroplasty - a Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total knee arthroplasty(TKA) is an effective modality for the treatment of advanced
      osteoarthritis of the knee joint with excellent outcomes. With 719,000 cases being performed
      as of 2010, the incidence is expected to increase up to 3.48 million procedures annually by
      2030.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There have been several studies regarding efficacy of peri articular infiltration. IPACK
      block is a novel technique gaining popularity where one injects local anesthesia safely under
      ultrasound guidance in the interspace between the popliteal artery and capsule of the knee.

      There have been no studies till date comparing the efficacy between IPACK block and
      Periarticular Infiltration (PAI).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Actual">June 1, 2019</completion_date>
  <primary_completion_date type="Actual">June 1, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Narcotic consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>Narcotic consumption in the first 24 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Score (VAS) for pain</measure>
    <time_frame>up to first 24 hours post procedure</time_frame>
    <description>Visual Analogue Score (VAS) for pain - scored from 0 (no pain) to 10 (extreme pain), that is, higher score indicates more pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first dose of narcotic administration</measure>
    <time_frame>average 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PACU length of stay</measure>
    <time_frame>average 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Location of pain</measure>
    <time_frame>24 hours</time_frame>
    <description>Location of knee pain as anterior/posterior, medial/lateral</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ambulation distance</measure>
    <time_frame>Post-op Day 1</time_frame>
    <description>Ambulation distance with assistance on POD 1 as assessed by PT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bartels index</measure>
    <time_frame>Post-op Day 1</time_frame>
    <description>Bartels Index to measure activities of daily living (ADL's) on POD 1 as assessed by OT. Total possible scores range from 0-20, with lower scores indicating increased disability.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Osteo Arthritis Knee</condition>
  <arm_group>
    <arm_group_label>Ipack group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 cc of bupivacaine(o.25%) will be injected with the help of ultrasound guidance. Patients will receive adductor canal catheter and peri articular infiltration as well.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pai (peri articular) group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive adductor canal catheter and peri articular infiltration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ipack</intervention_name>
    <description>IPACK block - local anesthesia injected safely under ultrasound guidance in the interspace between the popliteal artery and capsule of the knee.</description>
    <arm_group_label>Ipack group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>20 cc of bupivacaine(o.25%) injection</description>
    <arm_group_label>Ipack group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Peri Articular Infiltration</intervention_name>
    <description>Adductor Canal Catheter and Peri Articular Infiltration</description>
    <arm_group_label>Ipack group</arm_group_label>
    <arm_group_label>Pai (peri articular) group</arm_group_label>
    <other_name>PAI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA (American Society of Anesthesiology) class I-IV

          -  age 18-75.

        Exclusion Criteria:

          -  ASA class V

          -  morbid obesity

          -  patient refusal

          -  patients with chronic pain or on pain medication

          -  allergy to LA

          -  patients receiving any additional regional techniques

          -  coagulopathy

          -  patients receiving systemic anticoagulation

          -  local infection and procedures anticipated to last more than 5 hours.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan H Lai, MD,MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ichan School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sankineani SR, Reddy ARC, Eachempati KK, Jangale A, Gurava Reddy AV. Comparison of adductor canal block and IPACK block (interspace between the popliteal artery and the capsule of the posterior knee) with adductor canal block alone after total knee arthroplasty: a prospective control trial on pain and knee function in immediate postoperative period. Eur J Orthop Surg Traumatol. 2018 Oct;28(7):1391-1395. doi: 10.1007/s00590-018-2218-7. Epub 2018 May 2.</citation>
    <PMID>29721648</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>August 28, 2018</study_first_submitted>
  <study_first_submitted_qc>August 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2018</study_first_posted>
  <last_update_submitted>April 9, 2020</last_update_submitted>
  <last_update_submitted_qc>April 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Yan Lai</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Total knee arthroplasty</keyword>
  <keyword>Peri articular infiltration</keyword>
  <keyword>Pack block</keyword>
  <keyword>Adductor canal catheter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

